Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

Frederic Baron, Myriam Labopin, Annalisa Ruggeri, Jan J. Cornelissen, Ellen Meijer, Henrik Sengeloev, Dietger Niederwieser, Marco R. De Groot, Harry C. Schouten, Noel Milpied, Didier Blaise, Bipin N. Savani, Eliane Gluckman, Mohamad Mohty, Arnon Nagler

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2794-2803
Number of pages10
JournalClinical Cancer Research
Volume24
Issue number12
DOIs
Publication statusPublished - 15 Jun 2018

Keywords

  • ACUTE MYELOID-LEUKEMIA
  • CORD-BLOOD TRANSPLANTATION
  • VERSUS-HOST-DISEASE
  • TOTAL-BODY IRRADIATION
  • 1ST COMPLETE REMISSION
  • BONE-MARROW-TRANSPLANTATION
  • MATCHED SIBLING DONORS
  • RELAPSE-FREE SURVIVAL
  • UNRELATED DONOR
  • HEMATOLOGIC MALIGNANCIES

Cite this